Suppr超能文献

反义寡核苷酸作为可变剪接调节剂的治疗潜力。

Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

作者信息

Sazani Peter, Kole Ryszard

机构信息

University of North Carolina, Lineberger Comprehensive Cancer Center, CB #7295, Chapel Hill, North Carolina 27599-7295, USA.

出版信息

J Clin Invest. 2003 Aug;112(4):481-6. doi: 10.1172/JCI19547.

Abstract

An estimated 60% of all human genes undergo alternative splicing, a highly regulated process that produces splice variants with different functions. Such variants have been linked to a variety of cancers, and genetic diseases such as thalassemia and cystic fibrosis. This Perspective describes a promising approach to RNA repair based on the use of antisense oligonucleotides to modulate alternative splicing and engender the production of therapeutic gene products.

摘要

据估计,所有人类基因中有60%会发生可变剪接,这是一个受到高度调控的过程,会产生具有不同功能的剪接变体。这些变体与多种癌症以及地中海贫血和囊性纤维化等遗传疾病有关。本观点文章描述了一种基于使用反义寡核苷酸来调节可变剪接并产生治疗性基因产物的有前景的RNA修复方法。

相似文献

2
Modulation of alternative splicing by antisense oligonucleotides.反义寡核苷酸对可变剪接的调控
Prog Mol Subcell Biol. 2003;31:217-39. doi: 10.1007/978-3-662-09728-1_8.
5
Splicing and dicing apoptosis genes.剪接和切割凋亡基因。
Nat Biotechnol. 1999 Nov;17(11):1064-5. doi: 10.1038/15048.
7
Antisense-mediated redirection of mRNA splicing.反义介导的mRNA剪接重定向
Cell Mol Life Sci. 2003 May;60(5):825-33. doi: 10.1007/s00018-003-3042-7.
8
Making antisense of splicing.破解剪接之谜
Curr Opin Mol Ther. 2005 Oct;7(5):476-82.

引用本文的文献

3
Targeting RNA structures with small molecules.小分子靶向 RNA 结构。
Nat Rev Drug Discov. 2022 Oct;21(10):736-762. doi: 10.1038/s41573-022-00521-4. Epub 2022 Aug 8.
6
PepFect14 Signaling and Transfection.PepFect14 信号转导与转染。
Methods Mol Biol. 2022;2383:229-246. doi: 10.1007/978-1-0716-1752-6_15.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验